IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 28 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $98,000 | -1.0% | 10,000 | 0.0% | 0.02% | +20.0% |
| Q1 2022 | $99,000 | -1.0% | 10,000 | 0.0% | 0.02% | +5.3% |
| Q4 2021 | $100,000 | 0.0% | 10,000 | 0.0% | 0.02% | -5.0% |
| Q3 2021 | $100,000 | -1.0% | 10,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $101,000 | +2.0% | 10,000 | 0.0% | 0.02% | -9.1% |
| Q1 2021 | $99,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |